Mirtazapine alters cue-associated methamphetamine seeking in rats
about
SB 206553, a putative 5-HT2C inverse agonist, attenuates methamphetamine-seeking in ratsMirtazapine, and mirtazapine-like compounds as possible pharmacotherapy for substance abuse disorders: evidence from the bench and the bedsideRole of cues and contexts on drug-seeking behaviourNucleus accumbens shell excitability is decreased by methamphetamine self-administration and increased by 5-HT2C receptor inverse agonism and agonism.Pharmacotherapeutic agents in the treatment of methamphetamine dependence.Methamphetamine-induced vascular changes lead to striatal hypoxia and dopamine reductionInvestigating Methamphetamine Craving Using the Extinction-Reinstatement Model in the Rat.Nicotine enhances the expression of a sucrose or cocaine conditioned place preference in adult male rats.Cocaine self-administration enhances excitatory responses of pyramidal neurons in the rat medial prefrontal cortex to human immunodeficiency virus-1 Tat.The atypical antidepressant mirtazapine attenuates expression of morphine-induced place preference and motor sensitization.The group II metabotropic glutamate receptor agonist, LY379268, decreases methamphetamine self-administration in rats.Using conditioned place preference to identify relapse prevention medications.Mirtazapine and ketanserin alter preference for gambling-like schedules of reinforcement in rats.Methamphetamine decreases CD4 T cell frequency and alters pro-inflammatory cytokine production in a model of drug abuse.Pharmacologically distinct pramipexole-mediated akinesia vs. risk-taking in a rat model of Parkinson's diseaseMethamphetamine self-administration results in persistent dopaminergic pathology: implications for Parkinson's disease risk and reward-seeking.Colon dysregulation in methamphetamine self-administering HIV-1 transgenic rats.Chronic dosing with mirtazapine does not produce sedation in rats.
P2860
Q21262960-ECA46E8E-4C45-4B10-99A2-0C773533C741Q24622161-23429AE1-6240-4DE5-9806-01F7AFB2294FQ26825476-DDB3E312-BE3F-413C-A386-AD8E4CACD3F6Q27305182-985A3B10-4E9A-4AEF-B9F4-C43FA05448F5Q30235058-C75E5C62-DD62-49B7-B88A-C3D9A69DC9F8Q35529280-4C1D8B1B-93B7-4749-B0E8-59232F18CF37Q35833732-973F8AAA-817B-40FD-8038-AE4F6646E8A0Q35922766-09E97377-AC06-4006-B162-1102D5FB80CDQ35945472-C50EFEDD-0D7E-4114-AE58-0AF36DE4581FQ36229381-96713FBD-2AB9-4DF9-A57D-570BEFA6B292Q37244439-E19AA174-7E0B-4303-8DFC-28070107E3C1Q38107338-F6B2B56B-8C69-4BE4-B20A-3CA69F061BFCQ38835538-90DDEC89-0086-4015-AA0E-23488F07E50CQ39624808-CD8C6AF8-45F5-4478-B224-4A7D4B2E75BFQ42290120-B23A4FC6-37E2-4675-8B29-88707AB5893BQ42459947-910D1122-4AD5-4BBA-AC8F-D14091B15B19Q47238850-4657C6D9-6A93-49A0-B382-F5E9F23CD6D4Q47931148-7AFC1BAE-6FCC-4DA3-A34D-3A3353C94471
P2860
Mirtazapine alters cue-associated methamphetamine seeking in rats
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Mirtazapine alters cue-associated methamphetamine seeking in rats
@ast
Mirtazapine alters cue-associated methamphetamine seeking in rats
@en
Mirtazapine alters cue-associated methamphetamine seeking in rats
@nl
type
label
Mirtazapine alters cue-associated methamphetamine seeking in rats
@ast
Mirtazapine alters cue-associated methamphetamine seeking in rats
@en
Mirtazapine alters cue-associated methamphetamine seeking in rats
@nl
prefLabel
Mirtazapine alters cue-associated methamphetamine seeking in rats
@ast
Mirtazapine alters cue-associated methamphetamine seeking in rats
@en
Mirtazapine alters cue-associated methamphetamine seeking in rats
@nl
P2860
P1476
Mirtazapine alters cue-associated methamphetamine seeking in rats
@en
P2093
Steven M Graves
T Celeste Napier
P2860
P304
P356
10.1016/J.BIOPSYCH.2010.09.032
P407
P577
2010-11-20T00:00:00Z